Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Pediatric rhabdoid tumors of kidney and brain show many differences in gene expression but share dysregulation of cell cycle and epigenetic effector genes.

Birks DK, Donson AM, Patel PR, Sufit A, Algar EM, Dunham C, Kleinschmidt-DeMasters BK, Handler MH, Vibhakar R, Foreman NK.

Pediatr Blood Cancer. 2013 Jul;60(7):1095-102. doi: 10.1002/pbc.24481. Epub 2013 Feb 4.

2.

Phosphoproteomic analysis reveals Smarcb1 dependent EGFR signaling in Malignant Rhabdoid tumor cells.

Darr J, Klochendler A, Isaac S, Geiger T, Eden A.

Mol Cancer. 2015 Sep 15;14:167. doi: 10.1186/s12943-015-0439-5. Erratum in: Mol Cancer. 2016;15:14. Geiger, Tami [Corrected to Geiger, Tamar].

3.

Rhabdoid tumors: an initial clue to the role of chromatin remodeling in cancer.

Lee RS, Roberts CW.

Brain Pathol. 2013 Mar;23(2):200-5. doi: 10.1111/bpa.12021. Review.

PMID:
23432645
4.

SNF5 reexpression in malignant rhabdoid tumors regulates transcription of target genes by recruitment of SWI/SNF complexes and RNAPII to the transcription start site of their promoters.

Kuwahara Y, Wei D, Durand J, Weissman BE.

Mol Cancer Res. 2013 Mar;11(3):251-60. doi: 10.1158/1541-7786.MCR-12-0390. Epub 2013 Jan 30.

5.

Rhabdoid tumor: gene expression clues to pathogenesis and potential therapeutic targets.

Gadd S, Sredni ST, Huang CC, Perlman EJ; Renal Tumor Committee of the Children's Oncology Group.

Lab Invest. 2010 May;90(5):724-38. doi: 10.1038/labinvest.2010.66. Epub 2010 Mar 8.

6.

Study of the gene expression and microRNA expression profiles of malignant rhabdoid tumors originated in the brain (AT/RT) and in the kidney (RTK).

Grupenmacher AT, Halpern AL, Bonaldo Mde F, Huang CC, Hamm CA, de Andrade A, Tomita T, Sredni ST.

Childs Nerv Syst. 2013 Nov;29(11):1977-83. doi: 10.1007/s00381-013-2268-4. Epub 2013 Sep 3.

PMID:
23999875
7.

Molecular genetics of atypical teratoid/rhabdoid tumor.

Biegel JA.

Neurosurg Focus. 2006 Jan 15;20(1):E11. Review.

PMID:
16459991
8.

Claudin 6 is a positive marker for atypical teratoid/rhabdoid tumors.

Birks DK, Kleinschmidt-DeMasters BK, Donson AM, Barton VN, McNatt SA, Foreman NK, Handler MH.

Brain Pathol. 2010 Jan;20(1):140-50. doi: 10.1111/j.1750-3639.2008.00255.x. Epub 2009 Feb 9.

PMID:
19220299
9.

Rhabdoid tumors: integrating biological insights with clinical success: a report from the SMARCB1 and Rhabdoid Tumor Symposium, Paris, December 12-14, 2013.

Bourdeaut F, Chi SN, Frühwald MC.

Cancer Genet. 2014 Sep;207(9):346-51. doi: 10.1016/j.cancergen.2014.10.004. Epub 2014 Oct 24.

PMID:
25468731
10.

Nonsense mutation and inactivation of SMARCA4 (BRG1) in an atypical teratoid/rhabdoid tumor showing retained SMARCB1 (INI1) expression.

Hasselblatt M, Gesk S, Oyen F, Rossi S, Viscardi E, Giangaspero F, Giannini C, Judkins AR, Frühwald MC, Obser T, Schneppenheim R, Siebert R, Paulus W.

Am J Surg Pathol. 2011 Jun;35(6):933-5. doi: 10.1097/PAS.0b013e3182196a39.

PMID:
21566516
11.

Immunohistochemical expression of embryonic stem cell markers in malignant rhabdoid tumors.

Deisch J, Raisanen J, Rakheja D.

Pediatr Dev Pathol. 2011 Sep-Oct;14(5):353-9. doi: 10.2350/10-09-0902-OA.1. Epub 2011 Mar 21.

PMID:
21417895
12.

Aurora A is a repressed effector target of the chromatin remodeling protein INI1/hSNF5 required for rhabdoid tumor cell survival.

Lee S, Cimica V, Ramachandra N, Zagzag D, Kalpana GV.

Cancer Res. 2011 May 1;71(9):3225-35. doi: 10.1158/0008-5472.CAN-10-2167. Epub 2011 Apr 26.

13.

Molecular array analyses of 51 pediatric tumors shows overlap between malignant intracranial ectomesenchymoma and MPNST but not medulloblastoma or atypical teratoid rhabdoid tumor.

Kleinschmidt-DeMasters BK, Lovell MA, Donson AM, Wilkinson CC, Madden JR, Addo-Yobo SO, Lillehei KO, Foreman NK.

Acta Neuropathol. 2007 Jun;113(6):695-703. Epub 2007 Mar 13.

PMID:
17431644
14.

Analysis of the antiproliferative effects of 3-deazaneoplanocin A in combination with standard anticancer agents in rhabdoid tumor cell lines.

Unland R, Borchardt C, Clemens D, Kool M, Dirksen U, Frühwald MC.

Anticancer Drugs. 2015 Mar;26(3):301-11. doi: 10.1097/CAD.0000000000000181.

PMID:
25415657
15.

SMARCB1 deletion by a complex three-way chromosomal translocation in an extrarenal malignant rhabdoid tumor.

Bahrami A, Lee S, Caradine KD, Raimondi SC, Folpe AL.

Cancer Genet. 2014 Sep;207(9):437-40. doi: 10.1016/j.cancergen.2014.08.002. Epub 2014 Aug 24.

PMID:
25312828
16.

SMARCB1 deficiency in tumors from the peripheral nervous system: a link between schwannomas and rhabdoid tumors?

Rizzo D, Fréneaux P, Brisse H, Louvrier C, Lequin D, Nicolas A, Ranchère D, Verkarre V, Jouvet A, Dufour C, Edan C, Stéphan JL, Orbach D, Sarnacki S, Pierron G, Parfait B, Peuchmaur M, Delattre O, Bourdeaut F.

Am J Surg Pathol. 2012 Jul;36(7):964-72. doi: 10.1097/PAS.0b013e31825798f1.

PMID:
22614000
17.

Differential microRNA expression profiles between malignant rhabdoid tumor and epithelioid sarcoma: miR193a-5p is suggested to downregulate SMARCB1 mRNA expression.

Kohashi K, Yamamoto H, Kumagai R, Yamada Y, Hotokebuchi Y, Taguchi T, Iwamoto Y, Oda Y.

Mod Pathol. 2014 Jun;27(6):832-9. doi: 10.1038/modpathol.2013.213. Epub 2013 Nov 29.

18.

Chromosome 22q deletions in atypical teratoid/rhabdoid tumors in adults.

Raisanen J, Biegel JA, Hatanpaa KJ, Judkins A, White CL, Perry A.

Brain Pathol. 2005 Jan;15(1):23-8.

PMID:
15779233
19.

Expression of the HOX genes and HOTAIR in atypical teratoid rhabdoid tumors and other pediatric brain tumors.

Chakravadhanula M, Ozols VV, Hampton CN, Zhou L, Catchpoole D, Bhardwaj RD.

Cancer Genet. 2014 Sep;207(9):425-8. doi: 10.1016/j.cancergen.2014.05.014. Epub 2014 Jun 10.

PMID:
25085602
20.

Malignant rhabdoid tumors express stem cell factors, which relate to the expression of EZH2 and Id proteins.

Venneti S, Le P, Martinez D, Xie SX, Sullivan LM, Rorke-Adams LB, Pawel B, Judkins AR.

Am J Surg Pathol. 2011 Oct;35(10):1463-72. doi: 10.1097/PAS.0b013e318224d2cd.

PMID:
21921784
Items per page

Supplemental Content

Write to the Help Desk